Efavirenz-Based Antiretroviral Therapy but Not Pregnancy Increased Unbound Piperaquine Exposure in Women during Malaria Chemoprevention
Antimicrobial Agents and Chemotherapy · 2023
DOI: 10.1128/aac.01427-22 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2023. Verfasst von Howard Hong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Drug Research Unit, Department of Clinical Pharmacy, University of California, San Francisco, California, USA. Hauptthemen laut MEDLINE: Antimalarials, Malaria, Quinolines, HIV Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NIAID NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Dihydroartemisinin-piperaquine (DP) is highly effective for malaria chemoprevention during pregnancy, but the standard dosing of DP that is used for nonpregnant adults may not be optimal for pregnant women. We previously reported that the pharmacokinetic exposure of total piperaquine (PQ; both bound and unbound to plasma proteins) is reduced significantly in the context of pregnancy or efavirenz (EFV)-based antiretroviral therapy (ART).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Drug Research Unit, Department of Clinical Pharmacy, University of California, San Francisco, California, USA.
- Infectious Disease Research Collaboration, Makerere University College of Health Sciences, Kampala, Uganda.
- Department of Medicine, University of California, San Francisco, California, USA.
ORCID-Profile: Howard Hong, Erika Wallender, Philip J Rosenthal, Liusheng Huang
Förderung
- NICHD NIH HHS
- NIAID NIH HHS
- NCATS NIH HHS
- HHS | National Institutes of Health
Zitieren
APA
Hong, H., Aslam-Mir, U., Kajubi, R., Wallender, E., Mwebaza, N., Dorsey, G., Rosenthal, P. J., Aweeka, F. T., & Huang, L. (2023). Efavirenz-Based Antiretroviral Therapy but Not Pregnancy Increased Unbound Piperaquine Exposure in Women during Malaria Chemoprevention. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01427-22
Vancouver
Hong H, Aslam-Mir U, Kajubi R, Wallender E, Mwebaza N, Dorsey G, et al. Efavirenz-Based Antiretroviral Therapy but Not Pregnancy Increased Unbound Piperaquine Exposure in Women during Malaria Chemoprevention. Antimicrobial Agents and Chemotherapy. 2023. doi:10.1128/aac.01427-22
BibTeX
@article{Hong2023,
author = {Hong, Howard and Aslam-Mir, Usman and Kajubi, Richard and Wallender, Erika and Mwebaza, Norah and Dorsey, Grant and Rosenthal, Philip J and Aweeka, Francesca T and Huang, Liusheng},
title = {Efavirenz-Based Antiretroviral Therapy but Not Pregnancy Increased Unbound Piperaquine Exposure in Women during Malaria Chemoprevention},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2023},
doi = {10.1128/aac.01427-22}
}
EUVIMED